Vertex Pharmaceuticals Incorporated (VRTX), operates as Biotechnology company in the United States, Europe & internationally. It offers transformative medicines for people with serious diseases of different age groups. It comes under Healthcare – Biotech sector & trades as “VRTX” ticker at Nasdaq.
In weekly, it favors bullish sequence & expect rally, while pullback holds above August-2025 low. It favors rally in (III), which will confirm, when it breaks above November-2024 high. Currently, it favors correction in ((2)) in 3 or 7 swings against 8.11.2025 low before next rally.
In weekly, it placed ((I)) at $306.08 high in July-2020 & ((II)) at October-2021 low of $176.36. Above there, it ended (I) of ((III)) at $519.88 high in November-2024 & (II) at $362.50 low in August-2025 low. Within (I), it ended I at $292.75 high, II at $233.01 low, III at $510.63 high, IV at $447.70 low & V at $519.88 high. Within extended III, it placed ((1)) at $324.75 high, ((2)) at $282.21 low, ((3)) at $448.40 high, ((4)) at $391.01 low & ((5)) at $510.63 high.
VRTX - Elliott Wave Latest Weekly View:
Below (I) high, it ended (II) in double three correction. It ended w at $377.85 low in December-2024, x at $519.68 high in March-2025 & y at $362.50 low in August-2025. Above there, it ended ((1)) at $507.92 high & favors pullback in ((2)) in 3 or 7 swings correction. Within ((1)), it ended (1) at $403.58 high, (2) at $374.17 low, (3) at $487.52 high, (4) as flat at $450.67 low & (5) at $507.92 high. It favors downside in (A) of ((2)) & expect minor downside, while bounce fail below $463.78 high. Later it should bounce soon in (B) as connector before another push lower. The next pullback in (C), should hold the trend channel to finish ((2)) before next rally continue. But if it breaks below August-2025 low, it can do double correction in (II) against October-2021 low. Buyers can look to enter the extreme area of (C) in ((2)) correction.
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
